Posters Overview
In this study, we summarised a comprehensive bioanalytical strategy of ADCs based on mass spectrometry platforms, including tandem mass spectrometry (MS/MS) and high-resolution mass spectrometry (HRMS). Including measurement for total antibody, conjugated antibody, free payload, conjugated payload, total payload, drug-to-antibody ratio (DAR), and biotransformation. A deep understanding of these contents is key to characterising ADC behaviour through drug discovery to development stages.
Complete the form to view and download this poster.
Stay Connected
Keep up with the latest news and insights.